Publications

Search our bibliography using the filters on the right-hand side.

Displaying 101 through 150 of 350 publications.

Laramee P, Brodtkorb TH, Rahnali N, Knight C, Barbosa C, Francois C, Toumi M, Daeppen JB, Rehm J. The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model. BMJ Open. 2014 Sep 16;4(9). doi: 10.1136/bmjopen-2014-005376

Francois C, Danchenko N, Williams VS, Nelson LM, Williams NJ, Yarr SR, DiBenedetti DB, Lancon C. Psychometric evaluation of the depression and family functioning scale (DFFS). Poster presented at the Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health – Diagnosis, Prevention and Treatment in Mental Health: Effectiveness and Comparative Effectiveness; September 26, 2014. Washington, DC. [abstract] J Ment Health Policy Econ. 2014 Sep; 17(Suppl 1):S5-6.

Guxens M, Garcia-Esteban R, Giorgis-Allemand L, Forns J, Badaloni C, Ballester F, Beelen R, Cesaroni G, Chatzi L, de Agostini M, de Nazelle A, Eeftens M, Fernandez MF, Fernandez-Somoano A, Forastiere F, Gehring U, Ghassabian A, Heude B, Jaddoe VW, Klumper C, Kogevinas M, Kramer U, Larroque B, Lertxundi A, Lertxuni N, Murcia M, Navel V, Nieuwenhuijsen M, Porta D, Ramos R, Roumeliotaki T, Slama R, Sorensen M, Stephanou EG, Sugiri D, Tardon A, Tiemeier H, Tiesler CM, Verhulst FC, Vrijkotte T, Wilhelm M, Brunekreef B, Pershagen G, Sunyer J. Air pollution during pregnancy and childhood cognitive and psychomotor development: six European birth cohorts. Epidemiology. 2014 Sep;25(5):636-47. doi: 10.1097/EDE.0000000000000133

Nagar SP, Patel A, Bali V, Aparasu RR. Prevalence and predictors of pediatric depression in the United States. Int J Pharm Sci Nanotech. 2014 Sep;7(3):91-7.

Ibañez A, Aguado J, Baez S, Huepe D, Lopez V, Ortega R, Sigman M, Mikulan E, Lischinsky L, Torrente F, Cetkovich M, Torralva T, Bekinschtein T, Manes F. From neural signatures of emotional modulation to social cognition: individual differences in healthy volunteers and psychiatric participants. Soc Cogn Affect Neur. 2014 Jul;9(7):939-50.

Candrilli SD, Karve SJ. Recent trends in hospitalizations related to post-traumatic stress disorder in the United States. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 3, 2014.

Kamat SA, Blanchette C, Wilson MR, Tangirala M, Earnshaw SR, Offord S, Gutierrez B, Eramo A, Baker RA. Healthcare cost savings associated with aripiprazole once-monthly (AOM) treatment among schizophrenia patients with psychiatric hospitalizations prior to AOM treatment initiation. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 3, 2014.

Karve S, Markowitz M, Fu DJ, Lindenmayer JP, Wang CC, Candrilli SD, Alphs L. Assessing medication adherence and healthcare utilization and cost patterns among hospital-discharged patients with schizoaffective disorder. Appl Health Econ Health Policy. 2014 Jun;12(3):335-46.

Luciano JV, Barrada JR, Aguado J, Osma J, García-Campayo J. Bifactor analysis and construct validity of the HADS: a cross-sectional and longitudinal study in fibromyalgia patients. Psychological Assessment. 2014 Jun;26(2):395-406.

Von Schéele B, Mauskopf J, Brodtkorb TH, Ainsworth C, Berardo CG, Patel A. Relationship between modeling technique and reported outcomes: case studies in models for the treatment of schizophrenia. Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):235-57. doi: 10.1586/14737167.2014.891443

Nagar SP, Mhatre S, Hatfeild MD, Aparasu RR. Patterns and predictors of antipsychotic usage among U.S. adults: a national co-morbidity survey replication study. Int J Pharm Sci Nanotech. 2014 Apr;7(2):52-68.

Lopez-Vicente M, Sunyer J, Forns J, Torrent M, Julvez J. Continuous Performance Test II outcomes in 11-year-old children with early ADHD symptoms: a longitudinal study. Neuropsychology. 2014 Mar;28(2):202-11. doi: 10.1037/neu0000048

Quteineh L, Vandenberghe F, Gholam Rezaee M, Choong E, Saigi-Morgui N, Delacretaz A, Preisig M, von Gunten A, Conus P, Eap C. CRTC3 polymorphisms are not associated with obesity in Swiss psychiatric populations. Poster presented at the 22nd European Congress of Psychiatry; March 2014. Munich, Germany. [abstract] The european journal of psychiatry. 2014; 29:1.

Wheeler A, Raspa M, Bann C, Bishop E, Hessl D, Sacco P, Bailey DBJr. Anxiety, attention problems, hyperactivity, and the aberrant behavior checklist in fragile x syndrome. Am J Med Genet A. 2014 Jan;164A(1):141-55. doi: 10.1002/ajmg.a.36232

Vandenberghe F, Gholam Rezaee M, Choong E, Saigi Morgui N, Delacretaz A, Preisig M, von Gunten A, Conus P, Eap C. Predictive values of appetite and early weight increase for long-term weight variation during psychotropic treatment. Poster presented at the 22nd European Congress of Psychiatry; March 2014. Munich, Germany. [abstract] The european journal of psychiatry. 2014; 29(Suppl 1):1. doi: 10.1016/S0924-9338(14)78597-9

Novick D, Montgomery W, Aguado J, Peng X, Brugnoli R, Maria Haro J. Impact of anxiety symptoms on outcomes of depression. A study in patients from Asia. Int J Psychiatry Clin Pract. 2013 Nov 5;17(Suppl 2):30-1. doi: 10.3109/13651501.2013.851555

von Scheele B, Mauskopf J, Brodtkorb T, Ainsworth C, Galani Berardo C, Patel A. Relationship between modelling approach and reported outcomes: case studies of models for the treatment of schizophrenia. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. [abstract] Value Health. 2013 Nov; 16(7):A589.

Novick D, Montgomery W, Aguado J, Kadziola Z, Peng X, Brugnoli R. Factors associated with pain persistence in patient with depression during a 3-month follow-up period. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. Amsterdam, The Netherlands. [abstract] Value Health. 2013 Nov; 16(7):A544.

Markowitz M, Karve S, Panish J, Candrilli SD, Alphs L. Antipsychotic adherence patterns and health care utilization and costs among patients discharged after a schizophrenia-related hospitalization. BMC Psychiatry. 2013 Oct 5;13:246. doi: 10.1186/1471-244X-13-246.

Deal L, Lewis SA, DiBenedetti DB, DeMuro-Mercon CJ. Development of a clinical outcome assessment for autism spectrum disorder. Presented at the 20th Annual Conference of the International Society for Quality of Life Research; October 2013.

Farreny A, Aguado J, Ochoa S, Haro JM, Usall J. The role of negative symptoms in the context of cognitive remediation for schizophrenia. Schizophr Res. 2013 Oct;150(1):58-63.

Baez S, Aguado J, Huepe D, Lopez V, Ortega R, Torralva T. Neural signatures of emotional modulation and social cognition: individual differences in healthy volunteers and psychiatric participants. Poster presented at the Fifty-Third Annual Meeting, Firenze Fiera Congress & Exhibition Center; October 2014. Florence, Italy. [abstract] Psychophysiology. 2013 Sep 5; 50(S1):S59. doi: 10.1111/psyp.12120

Wilson MR, Gutierrez B, Offord S, Zhao C, Beillat M, Eramo A, Earnshaw SR. Total healthcare cost-offset associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia. Poster presented at the US Psychiatric & Mental Health Congress; September 2013.

Novick D, Montgomery W, Aguado J, Kadziola Z, Peng X, Brugnoli R, Haro JM. Which somatic symptoms are associated with an unfavorable course in Asian patients with major depressive disorder? J Affect Disord. 2013 Jul;149(1-3):182-8.

Hitsman B, Hogarth L, Tseng L, Teige JC, Shadel WG, DiBenedetti DB, Danto S, Lee TC, Price LH, Niaura R. Dissociable effect of acute varenicline on tonic versus cue-provoked craving in non-treatment-motivated heavy smokers. Drug Alcohol Depend. 2013 Jun 1;130(1-3):135-41.

Novick D, Montgomery W, Aguado J, Kadziola Z, Peng X, Brugnoli R. Course of pain and outcomes of depression. Results from a three - month, prospective, observational study from Asia. Poster presented at the Eleventh Workshop on Costs and Assessment in Psychiatry; March 2013. Venice, Italy. [abstract] J Ment Health Policy Econ. 2013 Mar; 16(Suppl 1):S27-8.

Novick D, Montgomery W, Aguado J, Kadziola Z, Peng X, Brugnoli R. Does the presence of co-morbid conditions explain the impact of pain in depression outcomes? Poster presented at the Eleventh Workshop on Costs and Assessment in Psychiatry; March 2013. Venice, Italy. [abstract] J Ment Health Policy Econ. 2013 Mar; 16(1):S27.

Panish J, Karve S, Candrilli SD, Dirani R. Association between adherence to and persistence with atypical antipsychotics and psychiatric relapse among US Medicaid-enrolled patients with schizophrenia. J Pharm Health Serv Res. 2013 Mar 1;4(1):29-39.

Sacco P, Capkun-Niggli G, Zhang X, Jose R. The economic burden of fragile x syndrome: healthcare resource utilization in the United States. Am Health Drug Benefits. 2013 Mar;6(2):73-83.

Ramos R, Freire C, Julvez J, Fernandez MF, Garcia-Esteban R, Torrent M, Sunyer J, Olea N. Association of ADHD symptoms and social competence with cognitive status in preschoolers. Eur Child Adolesc Psychiatry. 2013 Mar;22(3):153-64. doi: 10.1007/s00787-012-0334-1

Hodgkins P, Setyawan J, Mitra D, Davis K, Quintero J, Fridman M, Shaw M, Harpin V. Management of adhd in children across europe: patient demographics, physician characteristics and treatment patterns. Eur J Pediatr. 2013 Feb 1;172(7):895-906.

Farreny A, Aguado J, Ochoa S, Huerta-Ramos E, Marsà F, López-Carrilero R, Carral V, Haro JM, Usall J. REPYFLEC cognitive remediation group training in schizophrenia: looking for an integrative approach. Schizophr Res. 2012 Dec;142(1-3):137-44. doi: 10.1016/j.schres.2012.08.035.

Forns J, Lopez M, Alvararez-Pedrerol M, Julvez J, Sunyer J. Neuropsychological assessment in the BREATHE project. Poster presented at the DOHaD 2012 Satellite Meeting; December 2012. Rotterdam, the Netherlands.

Karve SJ, Panish JM, Dirani RG, Candrilli SD. Health care utilization and costs among Medicaid-enrolled patients with schizophrenia experiencing multiple psychiatric relapses. Health Outcomes Res Med. 2012 Nov 1;3(4):e183-94.

Forsyth B, Fehnel SE, Danchenko N, Franois C, Brevig T. Assessing impacts of major depressive disorder (MDD) on cognitive function. Value Health. 2012 Nov 1;15(7):A341.

Forsyth B, Fehnel SE, Danchenko N, François C, Brevig T. Assessing impacts of major depressive disorder on depression. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 1, 2012. Berlin, Germany.

Forsyth B, Fehnel SE, Danchenko N, François C, Brevig T. Patient-reported cognitive symptoms and a patient-reported outcome measure of cognitive function in depression. Poster presented at the Annual European College of Neuropsychopharmacology Congress; October 1, 2012.

Zoega H, Rothman KJ, Huybrechts KF, Olafsson O, Baldursson G, Almarsdottir AB, Jonsdottir S, Halldorsson M, Hernández-Díaz S, Valdimarsdottir UA. A population-based study of stimulant drug treatment of ADHD and academic progress in children. Pediatrics. 2012 Jul 1;130(1):e53-62.

Novick D, Montgomery W, Brnabic A, Aguado J, Kadziola Z, Peng X, Brugnoli R, Haro JM. Prognostic implications of somatic symptoms in patients with depression. Results from a three-month, prospective, observational study from Asia. Poster presented at the 28th CINP World Congress of Neuropsychopharmacology; June 3, 2012. Stockholm, Sweden. [abstract] Int J Neuropsychopharmacol. 2012 Jun; 15(1):191. doi: 10.1017/S1461145712000508

Eap CB, Vandenberghe F, Choong E, Saigi-Morgui N, Ambresin AE, von Gunten A, Conus P. Clinical and pharmacogenetic study on psychotropic drug induced weight gain and other metabolic complications in a Swiss psychiatric population. Poster presented at the 2012 World Congress of the International College of Neuropsychopharmacology; June 2012. Stockholm, Sweden. [abstract] Int J Neuropsychopharmacol. 2012 Jun 1; 15(Suppl 1):101. doi: 10.1017/S1461145712000508

Markowitz M, Karve S, Fu D, Lindenmayer J, Wang C, Candrilli S, Alphs L. Assessing medication adherence and health care utilization and cost patterns among hospital discharged patients with schizoaffective disorder. Poster presented at the 2012 American Psychiatric Association Annual Meeting; May 2012.

DiBenedetti DB, Danchenko N, Francois C, Lewis SA, Davis KH, Fehnel SE. Development of a family functioning scale for major depressive disorder. Curr Med Res Opin. 2012 Mar 1;28(3):303-13.

Huybrechts KF, Rothman KJ, Brookhart MA, Silliman RA, Crystal S, Gerhard T, Schneeweiss S. Variation in antipsychotic treatment choice across US nursing homes. J Clin Psychopharmacol. 2012 Feb 1;32(1):11-7.

Zimovetz EA, Wolowacz SE, Classi PM, Birt J. Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review. Cost Eff Resour Alloc. 2012 Feb 1;10(1):1.

Kitchen H, Rofail D, Heron L, Sacco P. Cognitive impairment associated with schizophrenia: a review of the humanistic burden. Adv Ther. 2012 Feb;29(2):148-62.

Graham CN, Mauskopf JA, Lawson AH, Ascher-Svanum H, Bruhn D. Updating and confirming an industry-sponsored pharmacoeconomic model: comparing two antipsychotics in the treatment of schizophrenia. Value Health. 2012 Jan 1;15(1):55-64.

Vandenberghe F, Choong E, Saigi-Morgui N, Quteineh L, Ambresin AE, von Gunten A, Conus P, Eap CB. Clinical study on psychotropic drug induced weight gain and other metabolic complications in a Swiss psychiatric population. Poster presented at the 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012; 21(Suppl 3):456. doi: 10.1002

Stull DE, Houghton K. Examining variability in depression among pre-retirees: innovative analytic methods applied to observational data. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A301.

Arana A, Arellano F, Suissa S. Suicide-related events in patients treated with antiepileptic drugs: not an example of time-window bias [Comment]. Epidemiology. 2011 Nov;22(6):876-7.

Karve S, Markowitz M, Panish J, Candrilli S, Cosmatos I, Alphs L. Assessing health care utilization and costs among hospital-discharged patients with schizophrenia. Poster presented at the 2011 US Psychiatric and Mental Health Congress; November 2011.